<!--
Generated by CaseThread CLI POC
Document Type: technology-transfer-agreement
Input File: cil-06-tech-transfer-manufacturing.yaml
Generated: 2025-07-09T00:37:41.511Z
Generation Time: 58s
-->

TECHNOLOGY TRANSFER AGREEMENT
================================

### Section 2: Parties  
This Technology Transfer Agreement ("Agreement") is entered into as of **March 15, 2024** ("Effective Date") by and between:

**ChemInnovate Labs, Inc.** ("Provider"), a corporation organized under the laws of Delaware, and  

**EcoWrap Industries, LLC** ("Recipient"), a limited liability company organized under the laws of Texas.

Provider and Recipient may be referred to individually as a "Party" and collectively as the "Parties."

---

### Section 3: Recitals  
WHEREAS, Provider has developed and owns certain technology in the field of biodegradable polymer manufacturing;

WHEREAS, Recipient desires to obtain rights to such technology for commercialization;

WHEREAS, Provider is willing to transfer such technology and provide associated know-how and support;

NOW, THEREFORE, in consideration of the mutual covenants contained herein, the Parties agree as follows:

---

### Section 4: Definitions  

1. DEFINITIONS  

1.1 "Technology" means the manufacturing process for BioPoly-X™ polymer production, quality control protocols and specifications, extrusion parameters for film production, formulation adjustments for different applications, and troubleshooting guides and best practices, including all related documentation, know-how, quality protocols, process parameters, and troubleshooting guides.  

1.2 "Know-How" means all technical information, data, materials, trade secrets, and expertise related to the Technology.  

1.3 "Confidential Information" means all non-public information disclosed by either Party.  

1.4 "Territory" means: worldwide.  

---

### Section 5: Technology Transfer  

2. TECHNOLOGY TRANSFER  

2.1 Grant of Rights. Provider hereby grants to Recipient **an exclusive license** to use, make, and commercialize the Technology in the Territory.  

2.2 Delivery. Provider shall deliver to Recipient within thirty (30) days after the Effective Date:  
&nbsp;&nbsp;(a) All documentation related to the Technology;  
&nbsp;&nbsp;(b) Physical materials and samples;  
&nbsp;&nbsp;(c) Know-How in written and electronic form.  

2.3 Transfer Method. Delivery shall be made via secure file transfer and/or physical shipment with appropriate confidentiality protections.

---

### Section 6: Training and Support  

3. TRAINING AND SUPPORT  

3.1 Training Program. Provider shall provide on-site training for up to eight (8) technical staff of Recipient at Recipient’s Houston facility for a period of two (2) weeks covering:  
&nbsp;&nbsp;• Equipment operation and maintenance  
&nbsp;&nbsp;• Process optimization  
&nbsp;&nbsp;• Quality testing procedures  
&nbsp;&nbsp;• Safety protocols  

3.2 Technical Support. Provider shall provide reasonable remote technical support for twelve (12) months following completion of the initial training.  

3.3 Documentation. Provider shall furnish comprehensive technical documentation and all updates issued during the support period.

---

### Section 7: Financial Terms  

4. FINANCIAL TERMS  

4.1 Technology Transfer Fee. Recipient shall pay Provider **US $750,000** within thirty (30) days of the Effective Date.  

4.2 Milestone Payments. Recipient shall pay the following milestone payments:  
&nbsp;&nbsp;(a) US $250,000 upon execution of this Agreement;  
&nbsp;&nbsp;(b) US $250,000 upon Provider’s delivery of all documentation under Section 2.2;  
&nbsp;&nbsp;(c) US $250,000 upon completion of the training program specified in Section 3.1.  

4.4 Payment Terms. All payments shall be made in U.S. dollars via wire transfer. Late payments bear interest at one and one-half percent (1.5 %) per month or the maximum rate allowed by law, whichever is lower.

---

### Section 8: Acceptance and Testing  

5. ACCEPTANCE  

5.1 Acceptance Period. Recipient shall have sixty (60) days after delivery of the Technology to test and evaluate it.  

5.2 Acceptance Criteria. The Technology shall be deemed accepted if it meets the specifications set forth in Exhibit A.  

5.3 Remedies. If the Technology fails acceptance, Provider shall have thirty (30) days to cure any deficiencies.  

5.4 Deemed Acceptance. The Technology will be deemed accepted if Recipient fails to provide written notice of deficiencies within the Acceptance Period.

---

### Section 9: Intellectual Property  

6. INTELLECTUAL PROPERTY  

6.1 Ownership. Provider retains all ownership rights in the Technology.  

6.2 Improvements. Recipient owns all improvements it makes to the Technology, and Provider receives a non-exclusive, royalty-free license to use such improvements.  

6.3 No Other Rights. No intellectual property rights are granted except as expressly stated herein.

---

### Section 10: Confidentiality  

7. CONFIDENTIALITY  

7.1 Obligations. Each Party shall maintain the other Party’s Confidential Information in strict confidence for ten (10) years from the Effective Date and shall use it solely for purposes of this Agreement.  

7.2 Exceptions. Confidentiality obligations do not apply to information that:  
&nbsp;&nbsp;(a) is or becomes publicly available without breach of this Agreement;  
&nbsp;&nbsp;(b) was rightfully known to the receiving Party before disclosure;  
&nbsp;&nbsp;(c) is independently developed without reference to the Confidential Information; or  
&nbsp;&nbsp;(d) is required to be disclosed by law or court order, provided the disclosing Party is given prompt notice.  

7.3 Return. Upon termination or expiration of this Agreement, each Party shall promptly return or destroy all Confidential Information of the other Party.

---

### Section 11: Warranties and Indemnification  

9. WARRANTIES  

9.1 Provider Warranties. Provider warrants that:  
&nbsp;&nbsp;(a) it has the right and authority to transfer the Technology;  
&nbsp;&nbsp;(b) to its knowledge, the Technology does not infringe any third-party intellectual property rights; and  
&nbsp;&nbsp;(c) the Technology will perform materially in accordance with the specifications in Exhibit A for a period of one (1) year from the date of acceptance.  

9.2 DISCLAIMER. EXCEPT AS EXPRESSLY SET FORTH IN THIS SECTION 9, THE TECHNOLOGY IS PROVIDED "AS IS" WITHOUT ANY WARRANTIES, WHETHER EXPRESS, IMPLIED, STATUTORY, OR OTHERWISE, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, AND NON-INFRINGEMENT.  

9.3 Indemnification. Each Party shall indemnify, defend, and hold harmless the other Party against any third-party claims arising out of breaches of its warranties or representations.

---

### Section 12: Term and Termination  

10. TERM AND TERMINATION  

10.1 Term. This Agreement shall remain in force for seven (7) years from the Effective Date.  

10.2 Termination. Either Party may terminate this Agreement for material breach by the other Party if such breach is not cured within sixty (60) days after written notice.  

10.3 Effect of Termination. Upon termination:  
&nbsp;&nbsp;(a) all licenses granted under this Agreement shall immediately terminate;  
&nbsp;&nbsp;(b) the confidentiality obligations in Section 7 shall survive; and  
&nbsp;&nbsp;(c) all accrued payment obligations shall remain due and payable.

---

### Section 13: General Provisions  

11. GENERAL PROVISIONS  

11.1 Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without regard to its conflict-of-law principles.  

11.2 Dispute Resolution. Any dispute arising out of or relating to this Agreement shall be resolved by binding arbitration under the rules of the American Arbitration Association (AAA) in Wilmington, Delaware. The arbitral award shall be final and may be entered in any court of competent jurisdiction.  

11.3 Entire Agreement. This Agreement, including all exhibits, constitutes the entire agreement between the Parties concerning its subject matter and supersedes all prior or contemporaneous agreements, understandings, or communications.  

11.4 Assignment. Neither Party may assign or transfer this Agreement or any of its rights or obligations hereunder without the prior written consent of the other Party, except to an affiliate or successor in connection with a merger, acquisition, or sale of substantially all assets. Any unauthorized assignment is null and void.

---

### Section 14: Signatures  

IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date.

| PROVIDER |  |
| --- | --- |
| **ChemInnovate Labs, Inc.** |  |
| By: _____________________________ |  |
| Name: Dr. James Liu |  |
| Title: Chief Executive Officer |  |
| Date: ___________________________ |  |

| RECIPIENT |  |
| --- | --- |
| **EcoWrap Industries, LLC** |  |
| By: _____________________________ |  |
| Name: Maria Santos |  |
| Title: President |  |
| Date: ___________________________ |  |